芳香烃受体信号通路相关基因多态性及mRNA在子宫内膜异位症发病中的相互作用

刘娟, 陈灿明, 徐杨, 张伟, 张磊

刘娟, 陈灿明, 徐杨, 张伟, 张磊. 芳香烃受体信号通路相关基因多态性及mRNA在子宫内膜异位症发病中的相互作用[J]. 实用临床医药杂志, 2019, 23(13): 1-5, 9. DOI: 10.7619/jcmp.201913001
引用本文: 刘娟, 陈灿明, 徐杨, 张伟, 张磊. 芳香烃受体信号通路相关基因多态性及mRNA在子宫内膜异位症发病中的相互作用[J]. 实用临床医药杂志, 2019, 23(13): 1-5, 9. DOI: 10.7619/jcmp.201913001
LIU Juan, CHEN Canming, XU Yang, ZHANG Wei, ZHANG Lei. Interaction between aromatic hydrocarbon receptor signaling pathway-related gene polymorphism and its mRNA in the development of endometriosis[J]. Journal of Clinical Medicine in Practice, 2019, 23(13): 1-5, 9. DOI: 10.7619/jcmp.201913001
Citation: LIU Juan, CHEN Canming, XU Yang, ZHANG Wei, ZHANG Lei. Interaction between aromatic hydrocarbon receptor signaling pathway-related gene polymorphism and its mRNA in the development of endometriosis[J]. Journal of Clinical Medicine in Practice, 2019, 23(13): 1-5, 9. DOI: 10.7619/jcmp.201913001

芳香烃受体信号通路相关基因多态性及mRNA在子宫内膜异位症发病中的相互作用

基金项目: 

江苏省卫生计生委课题 Z201524

江苏省扬州市重点研发计划-社会发展 YZ2015053

详细信息
    通讯作者:

    陈灿明, E-mail: njliu1978@126.com

  • 中图分类号: R711.71

Interaction between aromatic hydrocarbon receptor signaling pathway-related gene polymorphism and its mRNA in the development of endometriosis

  • 摘要:
      目的  探讨芳香烃受体(AhR)信号通路相关基因[AHR、AhR核异位蛋白(ARNT)、细胞色素P450 1A1(CYP1A1)、AhR阻遏蛋白(AhRR)、谷胱甘肽S转移酶1(GSTP1)、白细胞介素-1β(IL-1β)]多态性及mRNA在子宫内膜异位症(EMT)发病中的相互作用。
      方法  选择手术病理确诊为EMT的25例患者为病例组, 25例非EMT患者为对照组。实时定量PCR法检测mRNA表达,定量PCR为基础的高分辨率熔解曲线(PCR-HRM)法检测基因多态性,采用单纯病例研究方法对基因-基因交互作用进行分析。
      结果  病例组中AhR mRNA、GSTP1 mRNA和IL-1β mRNA水平较对照组显著增高(P < 0.01)。病例组中ARNT mRNA水平显著高于对照组(P < 0.05)。携带CYP1A1 rs4646903 CC突变基因型的个体发生EMT的危险度是TT纯合野生型的7.5倍(95%CI: 1.29~43.69), 其他基因多态性的分布组间比较无显著差异(P>0.05)。CYP1A1 6235 T/C突变型与ARNT 522 G/C突变型(OR=9.33, 95%CI: 1.47~59.48)、GSTP1313 A/G突变型(OR=13.50, 95%CI: 1.34~135.98)存在协同作用。AHR 1661 G/A突变型与AHRR 565 C/G突变型存在协同作用(OR=13.50, 95%CI: 1.34~159.98), 其他基因位点未见交互作用。
      结论  携带CYP1A1 rs4646903 CC基因型的个体发生EMT的风险性较高, CYP1A1 6235 T/C与ARNT 522 G/C突变型间的联合作用以及CYP1A1 6235 T/C与GSTP1313 A/G突变型间的联合作用与EMT的发病有关。
    Abstract:
      Objective  To explore the interaction between aromatic hydrocarbon receptor (AhR) signaling pathway-related genes [AHR, AhR nuclear heterotopic protein (ARNT), cytochrome P450 1A1 (CYP1A1), AhR repressor protein (AhRR), glutathione S-transferase 1 (GSTP1), interleukin-1β (IL-1β)] polymorphism and messenger RNA (mRNA) in endometriosis pathogenesis (EMT).
      Methods  A total of 25 patients with endometriosis confirmed by surgery and pathology were selected as case group (n=25), and 25 non-EMT patients were selected as control group (n=25). Gene polymorphism were detected by Polymerase Chain Reaction-High Resolution Melt (PCR-HRM) method, and expressions of mRNA were detected by real-time quantitative PCR in both groups. The gene-gene interactions were analyzed based on the simple-case-study method.
      Results  The levels of AhR, GSTP1 and IL-1β mRNAs in case group were significantly higher than those in control group (P < 0.01). The level of ARNT mRNA in case group increased significantly when compared with that in control group (P < 0.05). The risk of EMT in patients with CYP1A1 rs4646903 CC mutation genotype was 7.5 times higher than patients with homozygous wild genotype TT (95%CI: 1.29 to 43.69), and there were no significant differences in frequencies of other genotypes between case group and control group (P>0.05). The synergistic role of mutated CYP1A1 6235 T/C and mutated ARNT 522 G/C gene increased the risk of endometriosis (OR=9.33, 95%CI: 1.47 to 59.48), and the risk of disease also increased when combined with mutated CYP1A1 6235 T/C and mutated GSTP1313 A/G gene (OR=13.50, 95%CI: 1.34 to 135.98). Moreover, combined with mutated AHR 1661 G/A and AHRR 565 C/G appeared to cause a significant increase in endometriosis (OR=13.50, 95%CI: 1.34 to 159.98). No interaction was found at other loci.
      Conclusion  Patients with CYP1A1 rs4646903 CC gene has a high risk in developing endometriosis. The combined mutated genotypes (CYP1A1 6235 T/C and ARNT 522 G/C, CYP1A1 6235 T/C and GSTP1313 A/G) might be related with susceptibility to endometriosis.
  • 表  1   引物序列及PCR产物大小

    引物 序列 长度
    GAPDH 正义引物: CAATGACCCCTTCATTGACC; 106 bp
    反义引物: GACAAGCTTCCCGTTCTCAG
    AHR 正义引物: ACATCACCTACGCCAGTCG; 94 bp
    反义引物: CGCTTGGAAGGATTTGACTTGA
    ARNT 正义引物: TGACTCCTGTTTTGAACCAGC; 95 bp
    反义引物: CTGCTCACGAAGTTTATCCACAT
    CYP1A1 正义引物: TCGGCCACGGAGTTTCTTC; 141 bp
    反义引物: GGTCAGCATGTGCCCAATCA
    GSTP1 正义引物: CATCTACACCAACTATGAGGCG; 81 bp
    反义引物: AGCAGGGTCTCAAAAGGCTTC
    IL-1β 正义引物: ATGATGGCTTATTACAGTGGCAA 132 bp
    反义引物: GTCGGAGATTCGTAGCTGGA
    下载: 导出CSV

    表  2   病例组与对照组6个基因mRNA的表达水平(x±s)

    组别 n AHR mRNA AHRR mRNA ARNT mRNA CYP1A1 mRNA GSTP1 mRNA IL-1β mRNA
    病例组 25 3.05±1.00** 0.50±0.01 1.14±0.34* 0.94±0.33 4.26±0.28** 6.88±0.72**
    对照组 25 0.89±0.26 0.53±0.03 1.00±0.33 0.56±0.15 0.49±0.02 0.41±0.01
    与对照组比较, *P < 0.05, **P < 0.01。
    下载: 导出CSV

    表  3   AHR、ARNT、AHRR、CYP1A1、GSTP1、IL-1β基因多态性在病例组与对照组中分布[n(%)]

    基因型 病例组 对照组 OR(95%CI) P
    AHR 1661 G/A (rs2066853) GG 5(20.00) 5(20.00) Referent 1.00
    GA 12(48.00) 18(72.00) 0.67(0.16~2.81) 0.58
    AA 8(32.00) 2(8.00) 4.00(0.55~29.10) 0.17
    GA, AA 20(80.00) 20(80.00) 1.00(0.25~4.00 1.00
    ARNT 522 G/C (rs2228099) GG 5(20.00) 8(32.00) Referent
    CG 10(40.00) 12(48.00) 2.40(0.61~9.38) 0.21
    CC 10(40.00) 5(20.00) 3.20(0.68~15.07) 0.14
    CG, CC 20(80.00) 17(68.00) 0.53(1.15~1.93) 0.34
    AHRR 565 C/G (rs2292596) CC 5(20.00) 10(40.00) Referent
    CG 18(72.00) 15(60.00) 0.37(1.00~1.45) 0.37
    GG 2(8.00) 0
    CG, GG 20(80.00) 15(60.00) 0.44(0.02~9.03) 0.598
    CYP1A1 6235 T/C (rs4646903) TT 8(32.00) 10(40.00) Referent
    TC 5(20.00) 13(52.00) 0.48(0.12~1.93) 0.30
    CC 12(48.00) 2(8.00) 7.50(1.29~43.69) 0.03
    TC, CC 17(68.00) 15(60.00) 1.41(0.44~4.52) 0.56
    GSTP1 313 A/G (rs1695) AA 15(60.00) 15(60.00) Referent
    AG 8(32.00) 10(40.00) 1.25(0.39~4.04) 0.71
    GG 2(8.00) 0
    AG, GG 10(40.00) 10(40.00)
    IL-1β 3953 C/T (rs1143634) CC 25(100.00) 25(100.00)
    下载: 导出CSV

    表  4   基因-基因在EMT发病中的交互作用

    基因型 基因位点 OR(95%CI)
    TT TC+CC
    CYP1A1 6235 T/C ARNT 522 G/C CG+CCGSTP1 313 A/G AG+GG 1010 1515 9.33(1.47~59.48)13.50(1.34~135.98)
    AHR 1661 G/A AHRR 565 C/G CG+GG GG5 GA+AA20 13.5(1.34~159.98)
    下载: 导出CSV
  • [1] 李雷, 冷金花. 子宫内膜异位症相关生活质量的研究进展[J]. 中华医学杂志, 2017, 97(45): 3593-3596. doi: 10.3760/cma.j.issn.0376-2491.2017.45.017
    [2]

    Smarr M M, Kannan K, Buck Louis G M. Endocrine disrupting chemicals and endometriosis[J]. Fertil Steril, 2016, 106(4): 959-966. doi: 10.1016/j.fertnstert.2016.06.034

    [3]

    Porpora M G, Ingelido A M, di Domenico A, et al. Increased levels of polychlorobiphenyls in Italian women with endometriosis[J]. Chemosphere, 2006, 63(8): 1361-1367. doi: 10.1016/j.chemosphere.2005.09.022

    [4]

    De Felip E, Porpora M G, di Domenico A, et al. Dioxin-like compounds and endometriosis: a study on Italian and Belgian women of reproductive age[J]. Toxicol Lett, 2004, 150(2): 203-209. doi: 10.1016/j.toxlet.2004.01.008

    [5]

    Hoffman C S, Small C M, Blanck H M, et al. Endometriosis among women exposed to polybrominated biphenyls[J]. Ann Epidemiol, 2007, 17(7): 503-510. doi: 10.1016/j.annepidem.2006.11.005

    [6]

    Rier S E, Martin D C, Bowman R E, et al. Endometriosis in rhesus monkeys (Macaca mulatta) following chronic exposure to 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin[J]. Fundam Appl Toxicol, 1993, 21(4): 433-441. doi: 10.1006/faat.1993.1119

    [7] 刘娟, 任慕兰. 二噁英对小鼠异位子宫内膜中IL-1β表达的影响[J]. 中国妇幼健康研究, 2011, 22(2): 162-164. doi: 10.3969/j.issn.1673-5293.2011.02.015
    [8]

    Wen X, Xiong Y, Qu X L, et al. The risk of endometriosis after exposure to endocrine-disrupting chemicals: a meta-analysis of 30 epidemiology studies[J]. Gynecol Endocrinol, 2019: 1-6. doi: 10.1080/09513590.2019.1590546

    [9] 陈苏, 周子寒, 阳晓敏, 等. 环境内分泌干扰物暴露与子宫内膜异位症[J]. 现代预防医学, 2018, 45(22): 4058-4061. https://www.cnki.com.cn/Article/CJFDTOTAL-XDYF201822008.htm
    [10] 沈杨, 刘娟, 任慕兰, 等. 二噁英对小鼠异位子宫内膜影响的分子机制研究[J]. 中山大学学报: 医学科学版, 2010, 31(5): 608-613. https://www.cnki.com.cn/Article/CJFDTOTAL-ZSYK201005007.htm
    [11] 曹现岭, 孙振高. 子宫内膜异位症的遗传学发病机制研究进展[J]. 国际生殖健康/计划生育杂志, 2019, 38(1): 67-70, 82. doi: 10.3969/j.issn.1674-1889.2019.01.014
    [12] 庞朋沙, 过倩萍, 伍会健, 等. 细胞内AhR信号转导通路的机制研究[J]. 现代生物医学进展, 2010, 10(13): 2567-2570. https://www.cnki.com.cn/Article/CJFDTOTAL-SWCX201013061.htm
    [13]

    Guo S W. The association of endometriosis risk and genetic polymorphisms involving dioxin detoxification enzymes: a systematic review[J]. Eur J Obstet Gynecol Reprod Biol, 2006, 124(2): 134-143. doi: 10.1016/j.ejogrb.2005.10.002

    [14] 安晓汾, 杨丽萍, 刘淑娟, 等. CYP1A1基因多态性与吉林籍汉族女性子宫内膜异位症易感性的研究[J]. 中国妇幼保健, 2011, 26(14): 2174-2176. https://www.cnki.com.cn/Article/CJFDTOTAL-ZFYB201114042.htm
    [15]

    Matsuzaka Y, Kikuti Y Y, Goya K, et al. Lack of an association human dioxin detoxification gene polymorphisms with endometriosis in Japanese women: results of a pilot study[J]. Environ Health Prev Med, 2012, 17(6): 512-517. doi: 10.1007/s12199-012-0281-y

    [16]

    Juo S H, Wang T N, Lee J N, et al. CYP17, CYP1A1 and COMT polymorphisms and the risk of adenomyosis and endometriosis in Taiwanese women[J]. Hum Reprod, 2006, 21(6): 1498-1502. doi: 10.1093/humrep/del033

    [17]

    Babu K A, Reddy N G, Deendayal M, et al. GSTM1, GSTT1 and CYP1A1 detoxification gene polymorphisms and their relationship with advanced stages of endometriosis in South Indian women[J]. Pharmacogenet Genomics, 2005, 15(3): 167-172. doi: 10.1097/01213011-200503000-00005

    [18] 王玉凤, 宗利丽, 赵欣, 等. 中国南方妇女AhR和ARNT基因多态性与子宫内膜异位症的相关性[J]. 中华医学遗传学杂志, 2011, 28(2): 195-198. doi: 10.3760/cma.j.issn.1003-9406.2011.02.016
    [19] 杨丽萍, 安晓汾. 吉林市汉族妇女GSTM1基因和CYP1A1基因Exon7位点多态性与子宫内膜异位症易感性的研究[J]. 中国妇幼保健, 2009, 24(18): 2556-2559. https://www.cnki.com.cn/Article/CJFDTOTAL-ZFYB200918039.htm
    [20] 陈志芳, 丁岩, 林仁勇, 等. CYP1A1 MspI多态性及其合并GSTM1基因缺失与子宫内膜异位症的关系[J]. 现代妇产科进展, 2005, 14(4): 285-288. doi: 10.3969/j.issn.1004-7379.2005.04.007
    [21]

    Fan W, Huang Z Y, Xiao Z, et al. The cytochrome P4501A1 gene polymorphisms and endometriosis: a meta-analysis[J]. J Assist Reprod Genet, 2016, 33(10): 1373-1383. doi: 10.1007/s10815-016-0783-4

    [22]

    Wu C H, Guo C Y, Yang J G, et al. Polymorphisms of dioxin receptor complex components and detoxification-related genes jointly confer susceptibility to advanced-stage endometriosis in the taiwanese han population[J]. Am J Reprod Immunol, 2012, 67(2): 160-168. doi: 10.1111/j.1600-0897.2011.01077.x

    [23] 任伟俏, 孙高高, 李晶, 等. 子宫内膜异位症患者血清CD38、缩宫素、白介素-1β表达情况及相关性研究[J]. 中国妇幼保健, 2019, 34(7): 1660-1663. https://www.cnki.com.cn/Article/CJFDTOTAL-ZFYB201907067.htm
    [24] 温洁, 邓琳, 张信美, 等. 白细胞介素-1家族基因多态性与子宫内膜异位症的相关性研究[J]. 浙江大学学报: 医学版, 2006, 35(6): 653-657. doi: 10.3785/j.issn.1008-9292.2006.06.014
    [25] 王志红, 赵虎, 袁博, 等. 子宫内膜异位症相关卵巢癌和卵巢子宫内膜异位症患者血清CA125和Smac水平比较[J]. 肿瘤基础与临床, 2019, 32(1): 18-20. doi: 10.3969/j.issn.1673-5412.2019.01.006
    [26] 杨颖, 李华, 万红丽. 核酪蛋白激酶和细胞周期蛋白依赖性激酶底物在子宫内膜异位症相关卵巢癌中的表达及临床意义[J]. 中国计划生育和妇产科, 2018, 10(11): 35-39. doi: 10.3969/j.issn.1674-4020.2018.11.09
    [27]

    Dominici R, Malferrari G, Mariani C, et al. The Interleukin 1-beta exonic (+3953) polymorphism does not alter in vitro protein secretion[J]. Exp Mol Pathol, 2002, 73(2): 139-141. doi: 10.1006/exmp.2002.2435

    [28] 钱欢欢, 戴辉华, 林明娟, 等. 子宫内膜异位症相关恶性肿瘤的研究进展[J]. 南京医科大学学报: 自然科学版, 2019, 39(3): 442-447. https://www.cnki.com.cn/Article/CJFDTOTAL-NJYK201903028.htm
    [29] 汤桑桑, 沈源明, 万小云. 子宫内膜异位症相关卵巢癌发生机制的研究进展[J]. 现代妇产科进展, 2018, 27(10): 788-791. https://www.cnki.com.cn/Article/CJFDTOTAL-XDFC201810019.htm
表(4)
计量
  • 文章访问数:  299
  • HTML全文浏览量:  165
  • PDF下载量:  5
  • 被引次数: 0
出版历程
  • 收稿日期:  2019-03-15
  • 录用日期:  2019-04-25
  • 网络出版日期:  2021-02-23
  • 发布日期:  2019-07-14

目录

    /

    返回文章
    返回
    x 关闭 永久关闭